Michael Cram

Title: Michael Cram: Innovator in Pharmaceutical Formulations

Introduction

Michael Cram is a notable inventor based in Sandwich, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of formulations for intravenous administration. With a total of 2 patents to his name, Cram's work is recognized for its potential impact on patient care.

Latest Patents

Cram's latest patents focus on formulations of a PI3K/mTOR-inhibitor for intravenous administration. The first patent describes a pharmaceutical aqueous formulation comprising 1-(4-{[4-(dimethylamino)piperidin-1-yl]carbonyl}phenyl)-3-[4-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)phenyl]urea, or a pharmaceutically acceptable salt thereof, that is a clear solution. This formulation is particularly suitable for intravenous or parenteral administration to a patient. The second patent also relates to a similar formulation, emphasizing the importance of clear solutions for effective delivery.

Career Highlights

Michael Cram is currently associated with Pfizer Corporation, a leading global pharmaceutical company. His work at Pfizer has allowed him to focus on innovative solutions that enhance drug delivery methods. Cram's expertise in pharmaceutical formulations has positioned him as a valuable asset in the industry.

Collaborations

Cram has collaborated with several talented individuals in his field, including Kevin Richard Back and Aidan James Harper. These collaborations have fostered a creative environment that encourages innovation and the development of new pharmaceutical solutions.

Conclusion

Michael Cram's contributions to pharmaceutical formulations demonstrate his commitment to improving patient care through innovation. His patents reflect a deep understanding of the complexities involved in drug delivery systems. Cram's work continues to influence the pharmaceutical industry positively.